Evaluation of ⁶⁴Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates

• Main Authors: Hiroki Matsumoto (Author), Tadashi Watabe (Author), Chika Igarashi (Author), Tomoko Tachibana (Author), Fukiko Hihara (Author), Atsuo Waki (Author), Ming-Rong Zhang (Author), Hideaki Tashima (Author), Taiga Yamaya (Author), Kazuhiro Ooe (Author), Eku Shimosegawa (Author), Jun Hatazawa (Author), Sei Yoshida (Author), Kenichiro Naito (Author), Hiroaki Kurihara (Author), Makoto Ueno (Author), Kimiteru Ito (Author), Tatsuya Higashi (Author), Yukie Yoshii (Author)
• Formato: Libro
• Publicado: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Objectives: To improve the prognosis of pancreatic cancer, new imaging methods to identify tumor lesions at a size of <1 cm are urgently needed. To approach this clinical issue, we developed a new method to detect small tumor lesions in the pancreas (≥3 mm) by positron emission tomography (PET) u...